Atlas Capital Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200
| Closed | -$15.6K | – | 991 |
|
|
2024
Q4 | $15.6K | Buy |
+200
| New | +$15.6K | ﹤0.01% | 740 |
|
|
2024
Q3 | – | Sell |
-200
| Closed | -$22.7K | – | 922 |
|
|
2024
Q2 | $22.7K | Buy |
+200
| New | +$22.7K | ﹤0.01% | 682 |
|
|
2024
Q1 | – | Sell |
-200
| Closed | -$24.8K | – | 911 |
|
|
2023
Q4 | $24.8K | Hold |
200
| – | – | ﹤0.01% | 673 |
|
|
2023
Q3 | $18.7K | Hold |
200
| – | – | ﹤0.01% | 642 |
|
|
2023
Q2 | $25.7K | Hold |
200
| – | – | ﹤0.01% | 649 |
|
|
2023
Q1 | $23.2K | Hold |
200
| – | – | ﹤0.01% | 663 |
|
|
2022
Q4 | $22.6K | Hold |
200
| – | – | ﹤0.01% | 652 |
|
|
2022
Q3 | $16.1K | Sell |
200
-244
| -55% | -$19.7K | ﹤0.01% | 671 |
|
|
2022
Q2 | $33.1K | Buy |
+444
| New | +$33.1K | 0.01% | 615 |
|